ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,043Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 2680

$1.19M Total Retail Price of All Prescriptions

Rank: 35 out of 2680

845 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 845 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 845 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 18,697 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 985 926 1 7
OMEPRAZOLE 852 690 2 2
LISINOPRIL 677 533 3 5
HYDROCODONE-ACETAMINOPHEN 636 429 S3 4 13
LEVOTHYROXINE SODIUM 634 487 5 4
WARFARIN SODIUM 602 567 6 12
SIMVASTATIN 582 488 7 1
AMLODIPINE BESYLATE 543 445 8 3
CITALOPRAM HBR 496 395 9 22
METOPROLOL SUCCINATE 489 463 10 11
ATENOLOL 432 361 11 14
PRAVASTATIN SODIUM 393 294 12 16
METOPROLOL TARTRATE 385 330 13 8
HYDROCHLOROTHIAZIDE 375 323 14 9
GABAPENTIN 335 264 15 21
FENTANYL 305 275 S2 16 102
PREDNISONE 297 278 17 45
ATORVASTATIN CALCIUM 283 209 18 10
METFORMIN HCL 264 139 19 6
POTASSIUM CHLORIDE 257 217 20 29
NAMENDA 251 251 21 43
SERTRALINE HCL 243 208 22 23
RANITIDINE HCL 226 171 23 35
CARVEDILOL 223 197 24 27
DIGOXIN 216 204 25 59
DONEPEZIL HCL 213 213 26 28
PANTOPRAZOLE SODIUM 207 174 27 44
TRAZODONE HCL 200 165 28 60
CLOPIDOGREL 194 156 29 30
ALENDRONATE SODIUM 193 168 30 20
RAMIPRIL 188 162 31 49
CRESTOR 188 134 31 15
POLYETHYLENE GLYCOL 3350 182 172 33 55
ADVAIR DISKUS 181 137 34 32
KLOR-CON 10 173 165 35 177
KLOR-CON M20 172 171 36 101
CHLORTHALIDONE 171 146 37 149
TRAMADOL HCL 169 133 38 33
GLIMEPIRIDE 167 115 39 51
NYSTATIN-TRIAMCINOLONE 165 153 40 140
COMBIVENT 159 145 41 129
FAMOTIDINE 154 139 42 65
FLUTICASONE PROPIONATE 151 82 43 38
MIRTAZAPINE 145 126 44 48
CYMBALTA 141 80 45 56
BUMETANIDE 139 119 46 225
PROAIR HFA 133 66 47 52
SPIRONOLACTONE 132 95 48 86
LOSARTAN POTASSIUM 131 105 49 18
DIOVAN 129 118 50 26
SPIRIVA 128 95 51 36
PLAVIX 127 107 52 41
LEVETIRACETAM 127 127 52 94
LYRICA 113 68 54 107
LANTUS 106 97 55 70
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 87 56 31
ALLOPURINOL 103 82 57 42
ISOSORBIDE MONONITRATE ER 100 94 58 57
ZOLPIDEM TARTRATE 98 55 59 17
METFORMIN HCL ER 97 66 60 53
VENLAFAXINE HCL ER 92 62 61 111
KLOR-CON M10 88 71 62 185
NEXIUM 83 46 63 19
ROPINIROLE HCL 83 71 63 143
TAMSULOSIN HCL 82 76 65 25
MORPHINE SULFATE ER 80 39 S2 66 209
LEVOFLOXACIN 80 69 66 108
MELOXICAM 77 52 68 50
DILTIAZEM ER 76 76 69 270
RISPERIDONE 75 75 70 67
CIPROFLOXACIN HCL 72 65 71 85
HUMALOG 71 45 72 246
JANUVIA 71 35 72 34
CEPHALEXIN 71 45 72 132
CELEBREX 70 63 75 75
LANTUS SOLOSTAR 69 45 76 68
TRIAMTERENE-HCTZ 69 49 76 89
QUINAPRIL HCL 68 49 78 79
OXYBUTYNIN CHLORIDE ER 65 42 79 135
DILTIAZEM 24HR ER 64 56 80 131
LIDODERM 64 59 80 74
IPRATROPIUM-ALBUTEROL 64 61 80 110
AMLODIPINE BESYLATE-BENAZEPRIL 62 48 83 58
HUMULIN 70-30 62 42 83 334
NYSTATIN 61 60 85 160
LIPITOR 58 34 86 78
PAROXETINE HCL 57 57 87 62
FENOFIBRATE 56 40 88 77
CYCLOBENZAPRINE HCL 56 19 R 88 95
VERAPAMIL ER 56 42 88 126
PROPRANOLOL HCL 56 43 88 158
NOVOLIN 70-30 55 55 92 277
LOSARTAN-HYDROCHLOROTHIAZIDE 54 54 93 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.